Skip to main content
SLAS Europe 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Tony B Awardee
Tony B Awardee
Food/Beverage Available
Food/Beverage Available
Data Science and AI Parallel Path
Data Science and AI Parallel Path
Lab Automation Parallel Path
Lab Automation Parallel Path
  1. Home

SLAS Europe 2024 Track Descriptions

Podium presentations will be organized into three educational tracks: Frontiers in Technology, Screening Applications & Diagnostics and Shaping the Future of Therapeutics. Track descriptions are listed below.

Frontiers in Technology

This track will feature presentations by renowned experts and innovators who are at the forefront of leveraging advanced technologies to significantly enhance laboratory screening, automation, and analysis. These technological advancements will be pivotal in driving scientific discovery forward. Moreover, the increasing volume of data generated from 'omics, high-content screening (HCS), drug discovery, and sample management has catalyzed the development of cutting-edge algorithms rooted in big data analytics and machine learning/artificial intelligence. Attendees can anticipate gaining valuable insights into the latest technological breakthroughs that have the potential to revolutionize their businesses and streamline their processes.

Co-chairs: Patricia Maguire (University College Dublin) and Mike Gray (GlaxoSmithKline)

Screening Applications in Diagnostics

This track aims to provide a clear view on how diagnostics and screening applications are evolving by taking into the account the medical and scientific challenges arising in the post-Covid era. This track will host renowned experts and innovators who will guide us through the latest technologies and breakthroughs that are influencing emerging topics. Topics will include new testing paradigms which are closer to patients (point-of-care or at-home testing), new automation technologies, sequencing of the human genome, and how AI and machine learning can help address global emerging threats such as anti-microbial resistance, antibiotic massive abuse, and sepsis management. Attendees can expect unique insights and hints on the latest technological innovations, while our presenters will shed more light on key trends that we should look for in the coming years.

Co-chairs: Ricard Martin (Qiagen) and Dominik Rubus (Rabus.Tech)


Shaping the Future of Therapeutics

This track aims to provide a better understanding of current approaches that significantly impact the journey of novel medicines from scientific discoveries to patient treatment. Over four sessions, you will explore how the combination of big data and artificial intelligence is transforming the traditional drug discovery process. Additionally, we will delve into how personalized medicine and drug repurposing influence patient outcomes. We'll discuss the future of safety, toxicology and efficacy studies in light of the FDA's recent decision to eliminate the requirement for animal testing. Finally, we will present the advantages and challenges in the discovery and delivery of oligo therapeutics.

Co-chairs: Magdalena Otrocka (Ardigen) and Annika Jenmalm Jensen (Karolinska Institutet)